共 116 条
[1]
Chen-Xu M(2019)Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and nutrition examination survey, 2007-2016 Arthritis Rheumatol 71 991-999
[2]
Yokose C(2015)Global epidemiology of gout: prevalence, incidence and risk factors Nat Rev Rheumatol 11 649-662
[3]
Rai SK(2018)Interpretation of management of acute and recurrent gout:a clinical practice guideline from the American College of Physicians Chin Gen Pract 21 1645-1647
[4]
Pillinger MH(2017)2016 updated EULAR evidence-based recommendations for the management of gout Ann Rheum Dis 76 29-42
[5]
Choi HK(2016)Does the initiation of urate-lowering treatment during an acute gout attack prolong the current episode and precipitate recurrent attacks: a systematic literature review Rheumatol Int 36 1747-1752
[6]
Kuo CF(2017)The British Society for Rheumatology Guideline for the Management of Gout Rheumatology 56 1056-1059
[7]
Grainge MJ(2015)Significance of the initiation time of urate-lowering therapy in gout patients: a retrospective research Joint Bone Spine 82 428-431
[8]
Zhang W(2019)Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare Clin Rheumatol 38 2233-2239
[9]
Doherty M(2015)Does starting allopurinol prolong acute treated gout? A randomized clinical trial J Clin Rheumatol 21 120-125
[10]
Xiong YF(2012)Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial Am J Med 125 1126-1134